24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Bumble, NextEra Energy, Wheaton Precious Metals and more.
The Friday afternoon analyst calls were focused on Biogen, 3D Systems, Duke Energy, Ford, and more.
Friday's top analyst calls included Akebia Therapeutics, Broadcom, DocuSign, Lululemon Athletica, NextEra Energy, Overstock.com, Shopify and Wayfair.
On Thursday, Akebia Therapeutics Inc. (NASDAQ: AKBA) announced topline results from the Phase 3 PRO2TECT studies evaluating the safety and efficacy of vadadustat in chronic kidney disease (CKD)....
Patients suffering anemia due to chronic kidney disease are sure to be content with new positive top-line results from two Phase 3 active-controlled pivotal studies.
Akebia Therapeutics and Keryx Biopharmaceuticals each saw their shares take a dive on Thursday following news that these two companies had agreed upon a merger.
The top analyst upgrades, downgrades and other research calls from Thursday include Amazon, Allergan, Borg Warner, Lam Research, Mellanox Technologies and Shake Shack.
Akebia Therapeutics saw its shares hit a new 52-week high in Tuesday’s session following a key licensing agreement with Vifor Pharma.
Akebia Therapeutics shares saw a handy gain on Tuesday after the company reported a new collaboration with Otsuka Pharmaceutical.
Thursday's top analyst calls include General Electric, 3M, Shopify, SunPower, Zafgen, CIT, Ericsson, Honeywell.
Akebia Therapeutics plans on raising capital, according to its most recent proposed public offering.
Akebia Therapeutics led the bulls early on Monday following news of what looks like a big commercialization partnership in Asia.
Monday's top analyst upgrades, downgrades and initiations include Abbott Labs, Bluebird Bio, Chipotle, Eli Lilly, Ferrari and Wells Fargo.
Over the past week, a few biotech companies made absolutely massive runs with at least 25% gains.
Akebia Therapeutics has had a rough time this year, but shares took a sharp left turn in Wednesday's session on news of positive study results.